Thoracic aortic aneurysm epidemiology and demographics: Difference between revisions
(New page: {{Template:Thoracic aortic aneurysm}} {{CMG}} '''Editor-in-Chief:''' Amjad AlMahameed, MD, MPH, RPVI, FACP. Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, USA ...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Template:Thoracic aortic aneurysm}} | {{Template:Thoracic aortic aneurysm}} | ||
{{CMG}} | {{CMG}}, Amjad AlMahameed, MD, MPH, RPVI, FACP. Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, USA | ||
{{AE}} {{AN}} | |||
==Overview== | |||
[[Aortic aneurysm]] is one of the 15 top causes of death in most series. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
TAAs are relatively uncommon with an estimated incidence between 6 and 10 new aneurysms per 100,000 person-years. TAAs are usually diagnosed after the sixth decade of life and they typically expand slowly (approximately 0.1-0.2 cm/year). The risk of rupture is closely related to aneurysm size (3% for TAAs <4 cm and 7% for >6 cm). These bioepidemiological characteristics support the current stand that screening for TAA is not recommended in the general population. Certain population substrates, such as those with history of [[Marfan's syndrome]], [[Turner's syndrome]], [[Ehlers-Danlos type IV syndrome]], familial thoracic aortic disease syndromes, and patients with [[bicuspid aortic valve]] should have imaging study to screen for TAAs. | *TAAs are relatively uncommon with an estimated incidence between 6 and 10 new aneurysms per 100,000 person-years. | ||
*TAAs are usually diagnosed after the sixth decade of life and they typically expand slowly (approximately 0.1-0.2 cm/year). The risk of rupture is closely related to aneurysm size (3% for TAAs <4 cm and 7% for >6 cm). | |||
*These bioepidemiological characteristics support the current stand that screening for TAA is not recommended in the general population. Certain population substrates, such as those with history of [[Marfan's syndrome]], [[Turner's syndrome]], [[Ehlers-Danlos type IV syndrome]], familial thoracic aortic disease syndromes, and patients with [[bicuspid aortic valve]] should have imaging study to screen for TAAs. | |||
*The widespread use of imaging techniques partly contribute to increased detection of thoracic aortic aneurysm in the elderly, consequently increasing its prevalence. | |||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
Revision as of 06:26, 7 October 2012
|
Thoracic aortic aneurysm Microchapters |
|
Differentiating Thoracic Aortic Aneurysm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Special Scenarios |
|
Case Studies |
|
Thoracic aortic aneurysm epidemiology and demographics On the Web |
|
FDA on Thoracic aortic aneurysm epidemiology and demographics |
|
CDC on Thoracic aortic aneurysm epidemiology and demographics |
|
Thoracic aortic aneurysm epidemiology and demographics in the news |
|
Blogs on Thoracic aortic aneurysm epidemiology and demographics |
|
Directions to Hospitals Treating Thoracic aortic aneurysm epidemiology and demographics |
|
Risk calculators and risk factors for Thoracic aortic aneurysm epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Amjad AlMahameed, MD, MPH, RPVI, FACP. Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, USA Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Aortic aneurysm is one of the 15 top causes of death in most series.
Epidemiology and Demographics
- TAAs are relatively uncommon with an estimated incidence between 6 and 10 new aneurysms per 100,000 person-years.
- TAAs are usually diagnosed after the sixth decade of life and they typically expand slowly (approximately 0.1-0.2 cm/year). The risk of rupture is closely related to aneurysm size (3% for TAAs <4 cm and 7% for >6 cm).
- These bioepidemiological characteristics support the current stand that screening for TAA is not recommended in the general population. Certain population substrates, such as those with history of Marfan's syndrome, Turner's syndrome, Ehlers-Danlos type IV syndrome, familial thoracic aortic disease syndromes, and patients with bicuspid aortic valve should have imaging study to screen for TAAs.
- The widespread use of imaging techniques partly contribute to increased detection of thoracic aortic aneurysm in the elderly, consequently increasing its prevalence.